Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Whiting Samuel
Chief Medical Officer at Tempest Therapeutics. Filing since 6 Jan 2022.
CIK 0001870373
Company
Date
Role
Action
Shares
Amount
Of holding
TPST
Tempest Therapeutics, Inc.
2 Jul 2024
Chief Medical Officer
Bought
4,672
$9.95K
95.3%
TPST
Tempest Therapeutics, Inc.
6 Jan 2022
Chief Medical Officer
Bought
1,700
$8.17K
846%
2 decisions on file.
